Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Baxter
Boehringer Ingelheim
McKinsey
Express Scripts

Last Updated: December 7, 2021

Volunteer for clinical trials for DEMECLOCYCLINE HYDROCHLORIDE at ClinicalTrialExchange

DrugPatentWatch Database Preview

DEMECLOCYCLINE HYDROCHLORIDE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Demeclocycline Hydrochloride patents expire, and when can generic versions of Demeclocycline Hydrochloride launch?

Demeclocycline Hydrochloride is a drug marketed by Akorn, Amneal Pharm, Barr, Epic Pharma Llc, and Impax Labs. and is included in five NDAs.

The generic ingredient in DEMECLOCYCLINE HYDROCHLORIDE is demeclocycline hydrochloride. There are eleven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the demeclocycline hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Demeclocycline Hydrochloride

A generic version of DEMECLOCYCLINE HYDROCHLORIDE was approved as demeclocycline hydrochloride by AMNEAL PHARM on February 27th, 2008.

  Try it Free

Drug patent expirations by year for DEMECLOCYCLINE HYDROCHLORIDE
Recent Clinical Trials for DEMECLOCYCLINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Massachusetts General HospitalPhase 1
Federal University of São PauloPhase 4
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4

See all DEMECLOCYCLINE HYDROCHLORIDE clinical trials

Pharmacology for DEMECLOCYCLINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for DEMECLOCYCLINE HYDROCHLORIDE

US Patents and Regulatory Information for DEMECLOCYCLINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn DEMECLOCYCLINE HYDROCHLORIDE demeclocycline hydrochloride TABLET;ORAL 065389-001 Dec 1, 2008 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Epic Pharma Llc DEMECLOCYCLINE HYDROCHLORIDE demeclocycline hydrochloride TABLET;ORAL 065447-001 Aug 18, 2015 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Amneal Pharm DEMECLOCYCLINE HYDROCHLORIDE demeclocycline hydrochloride TABLET;ORAL 065425-002 Feb 27, 2008 AB RX No Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Epic Pharma Llc DEMECLOCYCLINE HYDROCHLORIDE demeclocycline hydrochloride TABLET;ORAL 065447-002 Aug 18, 2015 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Akorn DEMECLOCYCLINE HYDROCHLORIDE demeclocycline hydrochloride TABLET;ORAL 065389-002 Dec 1, 2008 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Amneal Pharm DEMECLOCYCLINE HYDROCHLORIDE demeclocycline hydrochloride TABLET;ORAL 065425-001 Feb 27, 2008 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Colorcon
Boehringer Ingelheim
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.